HKMPF logo

HKMPF Hikma Pharmaceuticals PLC

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$22.00
+0.00 (+0.00%)

Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Inj…

Market Cap: $4.55Bwww.hikma.com

Price

No data yet.

Social Signal Score

58
5d
50
1 mentions
—
30d
60
2 mentions
—
60d
60
2 mentions
—
90d
63
4 mentions
—
news: 4

Analyst Ratings

2 analysts
Buyconsensus
Strong Buy 0Buy 1Hold 1Sell 0Strong Sell 0

Revenue

$1.70B+974.37%
$158.51M$673.34M$1.19B$1.70B
Dec 2006Jun 2026

Analyst Estimates

FY2025
$2.24
$2.18–$2.32
5 analysts
FY2026
$2.26+1% YoY
$2.23–$2.29
1 analysts
FY2027
$2.44+8% YoY
$2.40–$2.47
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Said Samih Taleb Darwazah
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,400
Beta
0.65
Country
GB
Piotroski score
6 / 9 (Middling)
Altman Z-score
2.67
www.hikma.com